- Report
- May 2025
- 185 Pages
Global
From €3184EUR$3,545USD£2,727GBP
€3538EUR$3,939USD£3,030GBP
- Report
- May 2025
- 182 Pages
Global
From €3184EUR$3,545USD£2,727GBP
€3538EUR$3,939USD£3,030GBP
- Report
- May 2025
- 175 Pages
Global
From €4032EUR$4,490USD£3,454GBP
- Report
- March 2025
- 200 Pages
Global
From €4032EUR$4,490USD£3,454GBP
- Report
- March 2025
- 200 Pages
Global
From €4032EUR$4,490USD£3,454GBP
- Report
- March 2025
- 175 Pages
Global
From €4032EUR$4,490USD£3,454GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3368EUR$3,750USD£2,884GBP
- Report
- August 2022
- 120 Pages
Global
From €4041EUR$4,500USD£3,461GBP
- Report
- June 2025
- 50 Pages
Global
From €2380EUR$2,650USD£2,038GBP
- Report
- June 2025
- 50 Pages
Global
From €2380EUR$2,650USD£2,038GBP
Prochlorperazine is a drug used to treat nausea, vomiting, and other gastrointestinal issues. It is a phenothiazine, a type of antiemetic, and is available in both oral and injectable forms. It works by blocking dopamine receptors in the brain, which helps reduce nausea and vomiting. It is also used to treat vertigo, anxiety, and schizophrenia.
Prochlorperazine is a widely used drug in the gastrointestinal market, as it is effective in treating nausea and vomiting. It is also used to treat motion sickness, and is sometimes used as a pre-operative medication to reduce anxiety. It is generally well tolerated, with few side effects.
Some companies that produce prochlorperazine include Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more